<DOC>
	<DOC>NCT01002079</DOC>
	<brief_summary>The purpose of the study is to determine if the concomitant administration of rifampin with BMS-708163 will affect the Pharmacokinetics of BMS-708163 and to assess safety and tolerability of co-administration BMS-708163 and rifampin</brief_summary>
	<brief_title>Drug-Drug Interaction Study With Rifampin</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy male and postmenopausal female subjects, 1855 yrs old inclusive Women of childbearing potential Tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>